Two Sigma Securities LLC Invests $229,000 in Sotera Health (NASDAQ:SHC)

Two Sigma Securities LLC bought a new stake in Sotera Health (NASDAQ:SHC) in the 4th quarter, Holdings Channel reports. The fund bought 16,771 shares of the company’s stock, valued at approximately $229,000.

A number of other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Sotera Health by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company’s stock valued at $204,154,000 after buying an additional 173,341 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Sotera Health by 27.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,143,955 shares of the company’s stock valued at $43,004,000 after purchasing an additional 673,979 shares during the last quarter. Two Seas Capital LP grew its stake in Sotera Health by 624.0% during the 4th quarter. Two Seas Capital LP now owns 2,896,136 shares of the company’s stock valued at $39,619,000 after purchasing an additional 2,496,136 shares in the last quarter. Geode Capital Management LLC increased its holdings in Sotera Health by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 2,780,445 shares of the company’s stock worth $38,048,000 after purchasing an additional 25,054 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Sotera Health by 45.1% in the 4th quarter. Bank of New York Mellon Corp now owns 1,630,736 shares of the company’s stock valued at $22,308,000 after purchasing an additional 507,147 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Stock Performance

Shares of SHC opened at $11.31 on Wednesday. The stock has a market capitalization of $3.21 billion, a PE ratio of 45.24 and a beta of 1.88. The business’s fifty day moving average price is $11.47 and its 200 day moving average price is $13.10. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a 12-month low of $9.53 and a 12-month high of $17.08.

Analysts Set New Price Targets

A number of brokerages recently issued reports on SHC. Piper Sandler dropped their price target on shares of Sotera Health from $15.00 to $13.00 and set a “neutral” rating for the company in a research note on Wednesday, April 23rd. Barclays decreased their price objective on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, April 10th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.20.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.